Delay in CE Approval for XVIVO’s Perfusion Solution for Heart Preservation
GOTHENBURG, SWEDEN / ACCESS Newswire / July 28, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV). The XVIVO Heart Assist Transport and the XVIVO Heart Assist Transport Perfusion Set have received CE approval. At the same time XVIVO estimates delays of approximately 6-12 months for the CE approval of XVIVO’s heart perfusion solution and supplement, which are […]